Harmony Biosciences Holdings Future Growth
Future criteria checks 4/6
Harmony Biosciences Holdings is forecast to grow earnings and revenue by 28.4% and 16.8% per annum respectively while EPS is expected to grow by 28.5% per annum.
Key information
28.4%
Earnings growth rate
28.5%
EPS growth rate
| Pharmaceuticals earnings growth | 23.8% |
| Revenue growth rate | 16.8% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 18 May 2024 |
Recent future growth updates
Recent updates
Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 03
These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely
Apr 04Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings
Feb 09Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Mar 21Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?
Dec 01Harmony Biosciences: In Harmony
Sep 23We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease
Aug 05Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M
Aug 02Harmony Biosciences: Steady Revenue Generator Looking For A Future
May 26Harmony Biosciences: Strong Growth At A Reasonable Price
Mar 04Our First Look At Harmony Biosciences
Nov 04Harmony Biosciences Holdings' (NASDAQ:HRMY) Promising Earnings May Rest On Soft Foundations
Aug 17Harmony Biosciences Is Likely To Trade Higher As Wakix Sales Build
Jul 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 990 | 294 | 334 | 362 | 6 |
| 12/31/2025 | 842 | 232 | 250 | 283 | 7 |
| 12/31/2024 | 712 | 141 | 179 | 215 | 8 |
| 3/31/2024 | 618 | 138 | 208 | 208 | N/A |
| 12/31/2023 | 582 | 129 | 219 | 219 | N/A |
| 9/30/2023 | 542 | 151 | 169 | 169 | N/A |
| 6/30/2023 | 499 | 200 | 161 | 162 | N/A |
| 3/31/2023 | 472 | 189 | 158 | 158 | N/A |
| 12/31/2022 | 438 | 181 | 104 | 144 | N/A |
| 9/30/2022 | 401 | 156 | 115 | 155 | N/A |
| 6/30/2022 | 364 | 58 | 90 | 131 | N/A |
| 3/31/2022 | 331 | 49 | 75 | 115 | N/A |
| 12/31/2021 | 305 | 35 | -2 | 99 | N/A |
| 9/30/2021 | 271 | 12 | -31 | 71 | N/A |
| 6/30/2021 | 235 | 17 | -53 | 49 | N/A |
| 3/31/2021 | 200 | -7 | -66 | 36 | N/A |
| 12/31/2020 | 160 | -64 | -5 | -3 | N/A |
| 9/30/2020 | 109 | -110 | -114 | -37 | N/A |
| 6/30/2020 | 64 | -146 | -146 | -69 | N/A |
| 3/31/2020 | 26 | -165 | -169 | -92 | N/A |
| 12/31/2019 | 6 | -187 | -203 | -75 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HRMY's forecast earnings growth (28.4% per year) is above the savings rate (2.4%).
Earnings vs Market: HRMY's earnings (28.4% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: HRMY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HRMY's revenue (16.8% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: HRMY's revenue (16.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HRMY's Return on Equity is forecast to be high in 3 years time